Little Green Pharma (ASX:LGP) is a vertically integrated medicinal cannabis company that cultivates, manufactures, and distributes high-quality GMP-grade medicinal cannabis products to patients and partners around the world. With two global production sites, one in Denmark and one in Western Australia, LGP has the capacity to produce over 33 tonnes of medicinal cannabis biomass per annum. The company's products are sold under its own-branded and white-label ranges, and are exported to a number of countries including the UK, Germany, France, and New Zealand. Little Green Pharma is also actively engaged in research and development, with a focus on developing new and innovative cannabinoid-based medicines.